Preclinical and clinical development of palbociclib and future perspectives.

Autor: de Dueñas EM; Medical Oncology Department, Provincial Hospital of Castellón, Av. Doctor Clará, 19, 12002, Castellón de la Plana, Spain. eduardo.martinez@hospitalprovincial.es., Gavila-Gregori J; Medical Oncology Department, Valencian Institute of Oncology, Valencia, Spain., Olmos-Antón S; Medical Oncology Department, Provincial Hospital of Castellón, Av. Doctor Clará, 19, 12002, Castellón de la Plana, Spain., Santaballa-Bertrán A; La Fe University Hospital, Valencia, Spain., Lluch-Hernández A; Clinic University Hospital of Valencia, Valencia, Spain., Espinal-Domínguez EJ; Oncology Unit, Pfizer Inc., Madrid, Spain., Rivero-Silva M; Oncology Unit, Pfizer Inc., Madrid, Spain., Llombart-Cussac A; Medical Oncology Department, Arnau de Vilanova University Hospital, Valencia, Spain.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2018 Sep; Vol. 20 (9), pp. 1136-1144. Date of Electronic Publication: 2018 Mar 21.